Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster

Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster

10.1128/CVI.00117-10

Saved in:

Bibliographic Details
Main Authors:	Russell, F.M., Carapetis, J.R., Satzke, C., Tikoduadua, L., Waqatakirewa, L., Chandra, R., Seduadua, A., Oftadeh, S., Cheung, Y.B., Gilbert, G.L., Mulholland, E.K.
Other Authors:	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
Format:	Article
Published:	2014
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/110609
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy
by: Russell, F.M., et al.
Published: (2014)

Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age
by: Russell, F.M., et al.
Published: (2014)

A cost-effectiveness analysis of the 13-valent pneumococcal conjugated vaccine and the 23-valent pneumococcal polysaccharide vaccine among Thai older adult
by: Ngamprasertchai T.
Published: (2023)

Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine
by: Russell, F.M., et al.
Published: (2014)

A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIV
by: Wilck M.
Published: (2023)

Pneumococcal infection among children before introduction of 13-valent pneumococcal conjugate vaccine, Cambodia
by: Paul Turner, et al.
Published: (2018)

Pneumococcal colonization and severity of pneumonia in hospitalized Cambodian children following introduction of the 13-valent pneumococcal conjugate vaccine
by: Miliya T.
Published: (2023)

Nasopharyngeal carriage of streptococcus pneumoniae in gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings
by: Cheung, Y.-B., et al.
Published: (2014)

Kawasaki Disease following administration of 13-valent pneumococcal conjugate vaccine in young children
by: Yung, C.F., et al.
Published: (2021)

Kawasaki disease following administration of 13-valent pneumococcal conjugate vaccine in young children
by: Yung, Chee Fu, et al.
Published: (2020)

Impact of 13-Valent Pneumococcal Conjugate Vaccine on Colonization and Invasive Disease in Cambodian Children
by: Paul Turner, et al.
Published: (2020)

Clonal Expansion within Pneumococcal Serotype 6C after Use of Seven-Valent Vaccine
by: Loman N.J., et al.
Published: (2019)

Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV
by: Mohapi L.
Published: (2023)

Pneumococcal vaccine
by: V. Thamlikitkul
Published: (2018)

Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial
by: Russell, F.M., et al.
Published: (2014)

Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV
by: Lerato Mohapi, et al.
Published: (2022)

Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: Protection at what price in the Thai context?
by: Wantanee Kulpeng, et al.
Published: (2018)

Predictors for bacteremia in febrile sickle cell disease children in the post-7-valent pneumococcal conjugate vaccine era
by: Todd P. Chang, et al.
Published: (2018)

Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: protection at what price in the Thai context?
by: Wantanee Kulpenga, et al.
Published: (2014)

Pneumococcal carriage among high-risk adults in a country with nonmandatory pneumococcal vaccination during the coronavirus disease 2019 pandemic
by: Ngamprasertchai T.
Published: (2023)

A prospective study of urinary pneumococcal antigen detection in healthy Karen mothers with high rates of pneumococcal nasopharyngeal carriage
by: Paul Turner, et al.
Published: (2018)

Early signals of vaccine-driven perturbation seen in pneumococcal carriage population genomic data
by: Chrispin Chaguza, et al.
Published: (2020)

Adult invasive pneumococcal disease pre- and peri-pneumococcal conjugate vaccine introduction in a tertiary hospital in Singapore
by: Hsu, L.-Y., et al.
Published: (2015)

Molecular epidemiology of pneumococcal colonization in response to pneumococcal conjugate vaccination in children with recurrent acute otitis media
by: Bogaert, D, et al.
Published: (2020)

The PneuCarriage Project: A Multi-Centre Comparative Study to Identify the Best Serotyping Methods for Examining Pneumococcal Carriage in Vaccine Evaluation Studies
by: Catherine Satzke, et al.
Published: (2018)

Parental knowledge, attitudes and perception of pneumococcal disease and pneumococcal conjugate vaccines in Singapore: A questionnaire-based assessment
by: How, C.H, et al.
Published: (2020)

Continued control of pneumococcal disease in the UK - The impact of vaccination
by: Gladstone, R.A, et al.
Published: (2020)

Increase in serotype 6C pneumococcal carriage, United Kingdom
by: Tocheva, A.S, et al.
Published: (2020)

Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites
by: Feikin D.R., et al.
Published: (2019)

Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites
by: Daniel R. Feikin, et al.
Published: (2018)

A randomised trial to evaluate the immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Singapore and Malaysia
by: Lim, F.S, et al.
Published: (2020)

Pneumococcal disease in Thailand
by: Amgad Gamil, et al.
Published: (2022)

Acute Respiratory Infections and Child Survival: Potential Role of Pneumococcal vaccine control
by: Perpustakaan UGM, i-lib
Published: (1989)

An updated cost-effectiveness analysis of pneumococcal conjugate vaccine among children in Thailand
by: Piyameth Dilokthornsakul, et al.
Published: (2019)

Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis
by: Chen, C., et al.
Published: (2022)

Evidence for soft selective sweeps in the evolution of pneumococcal multidrug resistance and vaccine escape
by: Nicholas J. Croucher, et al.
Published: (2018)

Evidence for soft selective sweeps in the evolution of pneumococcal multidrug resistance and vaccine escape.
by: Croucher, Nicholas J., et al.
Published: (2015)

An updated cost-effectiveness analysis of pneumococcal conjugate vaccine among children in Thailand
by: Piyameth Dilokthornsakul, et al.
Published: (2020)

Efficacy of Pneumococcal Vaccine on Otitis Media: A Systematic Review and Meta-Analysis
by: Wannarong T.
Published: (2023)

Author Correction: Kawasaki Disease following administration of 13-valent pneumococcal conjugate vaccine in young children (Scientific Reports, (2019), 9, 1, (14705), 10.1038/s41598-019-51137-5)
by: Yung, Chee Fu, et al.
Published: (2022)